|
(V1311) |
AAV-mediated AP-1 decoy oligodeoxynucleotides expression inhibits aortic elastolysis in a mouse model for Marfan syndrome |
| |
|
A. Remes, R. Arif, M. Franz, A. Jungmann, M. Zaradzki, M. Hecker, M. Karck, K. Kallenbach, O. J. Müller, A. H. Wagner (Kiel, Heidelberg; Luxembourg, LU) |
|
|
Diskussion |
|
(V1312) |
Local reduction of Nudt6 enhances atherosclerotic lesion stability and limits progression of aortic aneurysms |
| |
|
H. Winter, H. Jin, E. Chernogubova, A. Bäcklund, A. Busch, L. Perisic Matic, U. Hedin, H. Eckstein, J. Pelisek, L. Maegdefessel (München; Stockholm, SE) |
|
|
Diskussion |
|
(V1313) |
Myeloperoxidase deficiency protects from vascular remodelling and aneurysm development in Marfan Syndrome |
| |
|
D. Mehrkens, M. Kochen, J. Dohr, A. Silva, M. Mollenhauer, G. Sengle, V. Rudolph, A. Klinke, M. Adam, S. Baldus (Köln, Bad Oeynhausen) |
|
|
Diskussion |
|
(V1314) |
A novel heterozygous variant in LOX leads to multiple aneurysms not only restricted to the thoracic aorta |
| |
|
A. Cirnu, K. Kolokotronis, S. Schraut, S. Rost, B. Gerull (Würzburg) |
|
|
Diskussion |
|
(V1315) |
Lack of LRP8 triggers the formation of aortic dissection in angiotensin II infused mice |
| |
|
L. Lagrange, S. Kossmann, W. Ruf, P. Wenzel (Mainz) |
|
|
Diskussion |
|
(V1316) |
Dissection and rupture of aortic aneurysms after inhibition of sphingosine-1-phosphate lyase |
| |
|
N. Schröder, K. Kaiser, G. Heusch, P. Keul, B. Levkau (Essen) |
|
|
Diskussion |